UPNRF yields 2.58% · JNJ yields 2.13%● Live data
📍 UPNRF pulled ahead of the other in Year 1
Combined, UPNRF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of UPNRF + JNJ for your $10,000?
Uponor Oyj provides plumbing, indoor climate, and infrastructure solutions in Europe and North America. The company operates through three segments: Building Solutions Europe, Building Solutions North America, and Uponor Infra. It offers drinking water delivery systems, including plastic plumbing pipe systems, multi-layer composite pipe systems for residential buildings, commercial and public buildings; underfloor heating and cooling, comprising floor integrated underfloor heating systems, water based floor heating, and electric underfloor heating for new buildings and renovation projects; wall heating and cooling systems radiant heating and cooling via the wall, for wet and dry plaster installation systems in new buildings and renovation projects. The company also provides ceiling heating and cooling for offices, sales areas, industrial buildings, and sports halls; room and supply temperature controls; mainfolds vario distribution units and cabinets, pre-assembled, and modern approach in residential buildings; flexible ecoflex pre-insulated pipes; prefabricated modules for plumbing and heating; heating and cooling products for projects; and radiator connections. Uponor Oyj was founded in 1918 and is based in Vantaa, Finland.
Full UPNRF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.